The search for therapeutic vaccines against cancer is a top priority in pharmaceutical research.
(Photo: Your_Photo_Today)
Frankfort, New York If you want to be important as a pharmaceutical company on the world market, you cannot avoid the USA. The largest economy in the world is by far the largest pharmaceutical market – and will remain so. According to the market research institute IQVia, more than 40 percent of the global pharmaceutical expenditure of 1.5 trillion dollars is attributable to the USA.
And those who also research and develop in the USA have the best market access. Overall, a location has developed there that offers research-based biotech and pharmaceutical companies attractive conditions. Five reasons why Germany should learn from the US.
1. More venture capital
Investors on the other side of the Atlantic are still investing significantly more venture capital in biotechnology than in Germany. The hype surrounding biotech companies triggered by the corona pandemic has subsided in the USA. Stock market valuations and venture capital inflows have also fallen significantly.
Read on now
Get access to this and every other article in the
Web and in our app free of charge for 4 weeks.
Further
Read on now
Get access to this and every other article in the
web and in our app.
Further